Chronic treatment with I‐dopa plus carbidopa in hemitransected rats: Preferential effects at intact dopamine synapses leading to behavioural signs of dopamine receptor supersensitivity
- 1 May 1983
- journal article
- research article
- Published by Wiley in Acta Physiologica Scandinavica
- Vol. 118 (1), 27-34
- https://doi.org/10.1111/j.1748-1716.1983.tb07236.x
Abstract
Chronic i. p. treatment with 1-dopa-carbidopa for 3 weeks in hemitransected male rats leads on one hand to tolerance to l-dopa induced turning behaviour and on the other hand to behavioural and biochemical signs of dopamine (DA) receptor supersensitivity on the intact side. Thus, the apomorphine induced ipsilateral turning behaviour is enhanced and the Kd values of the 3H-spiperone binding sites linked to DA receptors of the D2 type on the intact, but not on the denervated side are reduced by 40%. However, the number of 3H-spiperone binding sites is reduced by 20% in striatal membranes on the intact side after this type of treatment. Therefore, chronic treatment with a catecholamine (CA) precursor leads to selective adaptive changes at intact striatal DA synapses with certain signs of the expected development of DA receptor subsensitivity, but above all with signs of paradoxical development of DA receptor supersensitivity. A hypothesis is introduced to explain these results.This publication has 19 references indexed in Scilit:
- Modulation by cholecystokinins of 3H‐spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sitesActa Physiologica Scandinavica, 1981
- Complications of chronic levodopa therapyNeurology, 1981
- Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptidesJournal of Neural Transmission, 1981
- A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracingNeuroscience, 1980
- Levodopa with benserazide or carbidopa in Parkinson diseaseNeurology, 1979
- L-DOPA reversal of hyperdopaminergic behaviourLife Sciences, 1978
- Considerations in the management of parkinsonismNeurology, 1978
- 3H-spiroperidol labels dopamine receptors in pituitary and brainEuropean Journal of Pharmacology, 1977
- Blockade of α-methyltyrosine-induced supersensitivity to apomorphine by chronic administration of L-DOPALife Sciences, 1975
- The Pharmacology of Tardive DyskinesiasAmerican Journal of Psychiatry, 1973